Aspirin for the Prevention of Recurrent Venous Thromboembolism

Auteurs
Catégorie Primary study
Registry of Trialsclinicaltrials.gov
Year 2004
Loading references information
To determine whether aspirin is more effective than placebo for the prevention of recurrent symptomatic venous thromboembolism when given for at least two years after the initial 6-12 month of oral anticoagulant therapy in patients with idiopathic venous thromboembolism
Epistemonikos ID: 184ab50641fcaa35b962921859d6c112dc3e24a1
First added on: Apr 23, 2018